Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Oncology R&D Pipeline

Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Programs 5,539

Quick answer

Oncology: NovaPharmaNews indexes 5,539 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Top sponsors

Pipeline programs

Page 26 of 116

  1. exemestane

    Partner Therapeutics Limited

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  2. favezelimab/pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Colorectal Cancer

    phase 3 mab completed

    1 trial

  3. fianlimab

    Regeneron UK Limited

    Advanced Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  4. fianlimab

    Regeneron UK Limited

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  5. filgrastim

    Hospital Authority, Hong Kong

    Brain and Central Nervous System Tumors

    phase 3 mab completed

    2 trials

  6. filgrastim

    Solid Biosciences

    Ovarian Cancer

    phase 3 mab completed

    1 trial

  7. filgrastim

    Solid Biosciences

    Lymphoma

    phase 3 mab active

    2 trials

  8. filgrastim

    Solid Biosciences

    Lung Cancer

    phase 3 mab active

    1 trial

  9. folic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Neoplasms

    phase 3 small molecule active

    1 trial

  10. furmonertinib 240 mg oral, daily

    ArriVent BioPharma

    Metastatic Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  11. gemcitabine

    NORTHWEST BIOTHERAPEUTICS INC

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    1 trial

  12. gemcitabine and cisplatin (Induction chemotherapy)

    Sun Yat-sen University

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  13. gemcitabine and cisplatin (Induction chemotherapy)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  14. gene expression analysis

    United Therapeutics Europe Ltd

    Kidney Cancer

    phase 3 gene therapy active

    1 trial

  15. gilteritinib

    Astellas Pharma Inc

    Acute Myeloid Leukemia (AML)

    phase 3 small molecule completed

    1 trial

  16. golidocitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral T Cell Lymphoma

    phase 3 small molecule active

    1 trial

  17. imPaCT-PRO-01

    The George Institute

    Thromboprophylaxis in patients with advanced pancreatic cancer

    phase 3 small molecule active

    1 trial

  18. inotuzumab ozogamicin

    Pfizer

    Lymphoma, Follicular

    phase 3 small molecule terminated

    1 trial

  19. intensity-modulated radiation therapy

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 other active

    1 trial

  20. internal mammary nodal irradiation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    phase 3 other active

    1 trial

  21. lapatinib

    GlaxoSmithKline

    Neoplasms, Breast

    phase 3 small molecule completed

    1 trial

  22. lipegfilgrastim

    Teva Pharma GmbH

    Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

    phase 3 small molecule completed

    1 trial

  23. lomustine

    United Therapeutics Europe Ltd

    Brain and Central Nervous System Tumors

    phase 3 small molecule completed

    1 trial

  24. mCapOX plus Cetuximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer (CRC)

    phase 3 small molecule active

    1 trial

  25. metformin hydrochloride

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  26. mitomycin C-based hyperthermic intraperitoneal chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 3 other active

    1 trial

  27. nab-paclitaxel combined with carboplatin

    The First People's Hospital of Lianyungang

    Epithelial Ovarian Carcinoma Stage III

    phase 3 small molecule active

    1 trial

  28. neoadjuvant chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epithelial Ovarian Cancer

    phase 3 small molecule active

    1 trial

  29. neratinib

    PUMA BIOTECHNOLOGY, INC.

    HER2+ Metastatic Breast Cancer (MBC)

    phase 3 small molecule completed

    1 trial

  30. nivolumab

    Bristol-Myers Squibb

    Breast Cancer

    phase 3 mab completed

    1 trial

  31. non-pegylated liposomal doxorubicin

    Teva Pharma GmbH

    Tubular Breast Cancer Stage II

    phase 3 small molecule completed

    1 trial

  32. novel stent

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Cancer

    phase 3 other active

    1 trial

  33. obinutuzumab

    Hoffmann-La Roche

    Lymphocytic Leukemia, Chronic

    phase 3 small molecule completed

    1 trial

  34. obrixtamig

    Boehringer Ingelheim

    Small Cell Lung Cancer (SCLC)

    phase 3 small molecule active

    1 trial

  35. paclitaxel

    United Therapeutics Europe Ltd

    Germ Cell Tumor

    phase 3 small molecule active

    1 trial

  36. paclitaxel/anthracycline

    The First People's Hospital of Lianyungang

    Primary Breast Cancer

    phase 3 small molecule active

    1 trial

  37. patients undergo cVATS segmentectomy

    The First People's Hospital of Lianyungang

    Non-small Cell Lung Cancer Stage I

    phase 3 other active

    1 trial

  38. patients were assigned to receive TNT or iTNT management

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  39. pegcyte

    Biotech Pharmaceutical Co.,

    Breast Cancer Female

    phase 3 small molecule completed

    1 trial

  40. pegfilgrastim

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 mab active

    1 trial

  41. pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Non-small Cell Lung Cancer

    phase 3 mab completed

    2 trials

  42. pembrolizumab/vibostolimab

    Merck KGaA, Darmstadt, Germany

    Carcinoma, Non-Small-Cell Lung

    phase 3 mab active

    1 trial

  43. pemetrexed

    Eli Lilly and Company

    Head and Neck Neoplasms

    phase 3 small molecule completed

    1 trial

  44. placebo

    Takeda

    Non-cancer Pain

    phase 3 small molecule terminated

    1 trial

  45. placebo plus docetaxel

    Boehringer Ingelheim

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule completed

    1 trial

  46. postoperative antimicrobial prophylaxis

    Sun Yat-sen University

    Hepatocellular Carcinoma

    phase 3 small molecule on hold

    1 trial

  47. pralatrexate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Refractory Peripheral T-Cell Lymphoma

    phase 3 small molecule completed

    1 trial

  48. preoperative short-course radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Neoplasms

    phase 3 other terminated

    1 trial

Frequently asked questions

How many oncology pipeline programs are tracked?

5,539 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.